GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Navamedic ASA (FRA:N1A) » Definitions » Earnings per Share (Diluted)

Navamedic ASA (FRA:N1A) Earnings per Share (Diluted) : €0.02 (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Navamedic ASA Earnings per Share (Diluted)?

Navamedic ASA's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was €0.03. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.02.

Navamedic ASA's EPS (Basic) for the six months ended in Dec. 2023 was €0.03. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.02.

Navamedic ASA's EPS without NRI for the six months ended in Dec. 2023 was €0.10. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was €0.11.

During the past 12 months, Navamedic ASA's average EPS without NRIGrowth Rate was -36.90% per year.

During the past 13 years, Navamedic ASA's highest 3-Year average EPS without NRI Growth Rate was 71.60% per year. The lowest was -161.30% per year. And the median was -0.35% per year.


Navamedic ASA Earnings per Share (Diluted) Historical Data

The historical data trend for Navamedic ASA's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navamedic ASA Earnings per Share (Diluted) Chart

Navamedic ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 -0.11 - 0.17 0.02

Navamedic ASA Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.04 0.13 -0.01 0.03

Competitive Comparison of Navamedic ASA's Earnings per Share (Diluted)

For the Medical Distribution subindustry, Navamedic ASA's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Navamedic ASA's PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Navamedic ASA's PE Ratio distribution charts can be found below:

* The bar in red indicates where Navamedic ASA's PE Ratio falls into.



Navamedic ASA Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Navamedic ASA's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(0.287-0)/17.574
=0.02

Navamedic ASA's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(0.514-0)/17.574
=0.03

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Navamedic ASA  (FRA:N1A) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Navamedic ASA Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Navamedic ASA's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Navamedic ASA (FRA:N1A) Business Description

Traded in Other Exchanges
Address
Henrik Ibsensgate 100, Solli Plass, Lysaker, NOR, N-0255
Navamedic ASA is a pharmaceutical company that operates in a single segment, which is marketing, selling, and distributing pharmaceuticals and medical nutrition products to hospitals, pharmacies, and patients, bought from product suppliers and manufacturers in Europe and other places. Its product categories include Medical nutrition, Consumer health, Branded generics, and Specialty pharma.

Navamedic ASA (FRA:N1A) Headlines

No Headlines